ASHA-091

N/A

Report date: 2025/04/17 16:53:32
NME

Base Information

Drug NameASHA-091
Drug Alias NameASHA091ASHA-091
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDynamin-1-like protein inhibitors
TargetsDynamin-1-like protein
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeIschemiaReperfusion Injury +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsha Theraputics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAsha Theraputics LLC
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 SyndromeIschemiaReperfusion Injury +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A